BRIDGET HEHIR: Open Payments
NPI 1083098693 · PLYMOUTH, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 22 payments from 8 companies in 2025. Trend: 2023 $14 · 2024 $250 · 2025 $535
Food & beverage: $535
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $100 |
| Janssen Pharmaceuticals, Inc | 1 | $87 |
| Otsuka America Pharmaceutical, Inc. | 5 | $87 |
| ABBVIE INC. | 4 | $83 |
| Supernus Pharmaceuticals, Inc. | 4 | $83 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| Sage Therapeutics, LLC | 1 | $26 |
| Lundbeck LLC | 1 | $26 |
Products named: REXULTI, CAPLYTA, SPRAVATO, VRAYLAR, Qelbree, Auvelity, ZURZUVAE.
Industry payments across MI — which companies pay providers there.
